Abstract |
Emblica officinalis (EO) has antioxidant properties that could improve redox-sensitive vascular, cardiac and renal changes associated with deoxycorticosterone acetate/1% NaCl high salt ( DOCA/HS)-induced hypertension. We determined whether hydroalcoholic lyophilized extract of EO may influence DOCA/HS-induced hypertension by modulating activity of (p) eNOS and endogenous antioxidants. Hypertension was induced in rats by DOCA- salt (20 mg/kg, s.c.) twice weekly for 5 weeks and replacing drinking water with 1% NaCl solution. These rats received cotreatment of different doses of EO (75, 150 and 300 mg/kg/day) for 5 weeks. EO significantly decreased arterial blood pressure and heart rate along with cardiac and renal hypertrophy in a dose-dependent fashion as compared to DOCA control rats. Increased TBARS and decreased endogenous antioxidants including GSH, SOD and GSHPx activity in serum, heart and kidney tissues of hypertensive rats were also normalized. Furthermore, this antihypertensive activity of EO was also linked with increased serum NO, K(+) levels and decreased Na(+) levels. Moreover, EO robustly increased activated eNOS expression in heart. Our results demonstrate that EO reduces oxidative stress, prevents development and progression of hypertension as well as cardiac and renal hypertrophy in DOCA/HS-induced hypertension via modulation of activated eNOS, endogenous antioxidants, serum NO and electrolyte levels.
|
Authors | Jagriti Bhatia, Fauzia Tabassum, Ashok Kumar Sharma, Saurabh Bharti, Mahaveer Golechha, Sujata Joshi, Md Sayeed Akhatar, Abhay Krishna Srivastava, Dharamvir Singh Arya |
Journal | Cardiovascular toxicology
(Cardiovasc Toxicol)
Vol. 11
Issue 3
Pg. 272-9
(Sep 2011)
ISSN: 1559-0259 [Electronic] United States |
PMID | 21748534
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Plant Extracts
- Sodium Chloride, Dietary
- Thiobarbituric Acid Reactive Substances
- Nitric Oxide
- Desoxycorticosterone
- Glutathione Peroxidase
- Nitric Oxide Synthase Type III
- Nos3 protein, rat
- Superoxide Dismutase
- Glutathione
- Potassium
|
Topics |
- Animals
- Antihypertensive Agents
(pharmacology)
- Blood Pressure
(drug effects)
- Cardiomegaly
(enzymology, prevention & control)
- Desoxycorticosterone
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Glutathione
(metabolism)
- Glutathione Peroxidase
(metabolism)
- Hypertension
(chemically induced, drug therapy, enzymology, physiopathology)
- Kidney Diseases
(enzymology, prevention & control)
- Male
- Nitric Oxide
(blood)
- Nitric Oxide Synthase Type III
(metabolism)
- Oxidative Stress
(drug effects)
- Phosphorylation
- Phyllanthus emblica
- Plant Extracts
(pharmacology)
- Potassium
(blood)
- Rats
- Sodium Chloride, Dietary
(blood)
- Superoxide Dismutase
(metabolism)
- Thiobarbituric Acid Reactive Substances
(metabolism)
- Time Factors
|